Food & Function,
Journal Year:
2018,
Volume and Issue:
9(12), P. 6427 - 6434
Published: Jan. 1, 2018
Proposed
renoprotection
mechanism
of
LYC
via
enhancing
renal
antioxidant
in
AFB1-treated
mice
kidney.
The
→
indicates
activation
or
induction,
and
⊣
inhibition
blockade.
Toxins,
Journal Year:
2020,
Volume and Issue:
12(4), P. 227 - 227
Published: April 4, 2020
Persistent
low-grade
inflammation
and
premature
ageing
are
hallmarks
of
the
uremic
phenotype
contribute
to
impaired
health
status,
reduced
quality
life,
mortality
in
chronic
kidney
disease
(CKD).
Because
there
is
a
huge
global
burden
due
CKD,
treatment
strategies
targeting
CKD
particular
interest.
Several
distinct
features
may
represent
potential
options
attenuate
risk
progression
poor
outcome
CKD.
The
nuclear
factor
erythroid
2-related
2
(NRF2)–kelch-like
cell-derived
protein
with
CNC
homology
[ECH]-associated
1
(KEAP1)
signaling
pathway,
endocrine
phosphate-fibroblast
growth
factor-23–klotho
axis,
increased
cellular
senescence,
mitochondrial
biogenesis
currently
most
promising
candidates,
different
pharmaceutical
compounds
already
under
evaluation.
If
studies
humans
show
beneficial
effects,
carefully
phenotyped
patients
can
benefit
from
them.
Frontiers in Endocrinology,
Journal Year:
2020,
Volume and Issue:
11
Published: Aug. 27, 2020
Klotho
has
been
recognised
as
a
gene
involved
in
the
ageing
process
mammals
for
over
thirty
years,
where
it
regulates
phosphate
homeostasis
and
activity
of
members
fibroblast
growth
factor
(FGF)
family.
The
α
-Klotho
protein
is
receptor
Fibroblast
Growth
Factor-23
(FGF23),
regulating
vitamin
D
metabolism.
Phosphate
toxicity
hallmark
mammalian
correlates
with
diminution
levels
increasing
age.
As
such,
modulation
an
attractive
target
therapeutic
intervention
diseasome
ageing;
particular
chronic
kidney
disease
(CKD),
implicated
directly
pathophysiology.
A
range
senotherapeutic
strategies
have
developed
to
or
indirectly
influence
expression,
varying
degrees
success.
These
include
administration
exogenous
Klotho,
synthetic
natural
agonists
indirect
approaches,
via
foodome
gut
microbiota.
All
these
approaches
significant
potential
mitigate
loss
physiological
function
resilience
accompanying
old
age
improve
outcomes
within
ageing.
Molecular Aspects of Medicine,
Journal Year:
2022,
Volume and Issue:
86, P. 101099 - 101099
Published: June 8, 2022
Post-translational
modifications
(PTMs)
have
been
proposed
as
a
link
between
the
oxidative
stress-inflammation-ageing
trinity,
thereby
affecting
several
hallmarks
of
ageing.
Phosphorylation,
acetylation,
and
ubiquitination
cover
>90%
all
reported
PTMs.
Several
main
PTMs
are
involved
in
normal
"healthy"
ageing
different
age-related
diseases,
for
instance
neurodegenerative,
metabolic,
cardiovascular,
bone
well
cancer
chronic
kidney
disease.
Ultimately,
data
from
human
rare
progeroid
syndromes,
but
also
long-living
animal
species,
imply
that
critical
regulators
process.
Mechanistically,
target
epigenetic
non-epigenetic
pathways
during
In
particular,
histone
modification
has
implications
process
can
modulate
lifespan.
Therefore,
PTM-based
therapeutics
appear
to
be
attractive
pharmaceutical
candidates
reduce
burden
ageing-related
diseases.
phosphorylation
acetylation
inhibitors
already
FDA-approved
treatment
other
diseases
offer
unique
potential
investigate
both
beneficial
effects
possible
side-effects.
As
an
example,
most
well-studied
senolytic
compounds
dasatinib
quercetin,
which
tested
Phase
1
pilot
studies,
act
kinase
inhibitors,
targeting
cellular
senescence
increasing
Future
studies
need
carefully
determine
best
"diseasome
ageing".
Kidney International,
Journal Year:
2019,
Volume and Issue:
95(4), P. 958 - 972
Published: March 2, 2019
Children
on
dialysis
have
a
cardiovascular
mortality
risk
equivalent
to
older
adults
in
the
general
population,
and
rapidly
develop
medial
vascular
calcification,
an
age-associated
pathology.
We
hypothesized
that
premature
ageing
contributes
calcification
children
with
advanced
chronic
kidney
disease
(CKD).
Vessels
from
Stage
5
CKD
without
had
evidence
of
increased
oxidative
DNA
damage.
The
senescence
markers
p16
p21
were
also
vessels
dialysis.
Treatment
vessel
rings
ex
vivo
calcifying
media
damage
CKD,
but
not
those
healthy
controls.
Vascular
smooth
muscle
cells
cultured
exhibited
persistent
damage,
impaired
repair,
accelerated
senescence.
Under
conditions
showed
osteogenic
differentiation
calcification.
These
changes
correlated
activation
senescence-associated
secretory
phenotype
(SASP),
inflammatory
characterized
by
secretion
proinflammatory
cytokines
growth
factors.
Blockade
ataxia-telangiectasia
mutated
(ATM)-mediated
signaling
reduced
both
inflammation
Clinically,
elevated
circulating
levels
SASP
factors
stiffness
coronary
artery
data
imply
dysregulated
mineral
metabolism
drives
"inflammaging"
promoting
senescence,
pro-inflammatory
SASP.
Drugs
target
or
eliminate
senescent
may
potential
prevent
patients
CKD.Graphical
abstract
Computational and Structural Biotechnology Journal,
Journal Year:
2019,
Volume and Issue:
17, P. 721 - 729
Published: Jan. 1, 2019
Chronic
kidney
disease
(CKD)
is
a
clinical
model
of
premature
ageing
characterized
by
progressive
vascular
disease,
systemic
inflammation,
muscle
wasting
and
frailty.
The
predominant
early
(EVA)
process
mediated
medial
calcification
(VC)
results
in
marked
discrepancy
between
chronological
biological
age
CKD.
Though
the
exact
underlying
mechanisms
VC
EVA
are
not
fully
elucidated,
accumulating
evidence
indicates
that
cellular
senescence
-
subsequent
chronic
inflammation
through
senescence-associated
secretary
phenotype
(SASP)
plays
fundamental
role
its
initiation
progression.
In
this
review,
we
discuss
pathophysiological
links
CKD,
with
focus
on
media
VC,
potential
anti-ageing
therapeutic
strategies
senolytic
drugs
targeting
Frontiers in Pharmacology,
Journal Year:
2020,
Volume and Issue:
11
Published: July 23, 2020
Diabetic
nephropathy
(DN)
is
a
major
cause
of
end-stage
kidney
failure.
The
present
study
examines
the
amelioration
renal
protection
sinapic
acid
(SA)
in
streptozotocin
(STZ)-induced
diabetic
and
associated
mechanisms.
Rats
were
randomly
assigned
into
four
groups:
Normal
control
(NC),
STZ,
STZ
+
SA
20
mg/kg
bw,
40
bw.
After
eight
weeks,
fasting
blood
glucose
(FBG),
ratio
weight
to
body
(renal
index),
24
h
urine
protein,
urea
nitrogen
(BUN),
serum
creatinine
(SCr),
reduced
glutathione
peroxidase
(GPx),
superoxide
dismutase
(SOD),
lipid
peroxidation
(LPO),
inflammatory
marker
MPO,
tumor
necrosis
factor
α
(TNFα),
interleukin
(IL)-6,
as
well
profile
total
cholesterol
(TC),
triglycerides
(TG),
very
low
density
lipoprotein
(VLDL),
(LDL),
high
(HDL)
levels
assesed.
histomorphology
ultrastructure
kidneys
also
assessed.
In
addition,
protein
expression
transforming
growth
factor-β1
(TGF-β1),
nuclear
erythroid
2-related
2
(Nrf2),
heme
oxygenase-1
(HO-1),
IκBα
(IkBα),
anti-apoptotic
BCl2
,
kappa
B
(NF-kB),
Bax
examined.
We
found
that
pretreatment
significantly
dose-dependently
upregulated
Nrf2,
HO-1,
IKBα,
Bcl-2
but
downregulated
NF-κB,
suggesting
protective
mechanism
due
its
antioxidant
activity;
prevents
release
pro-inflammatory
cytokines
markers
(TNFα
IL-6
MPO),
upregulates
defence
enzymes,
reduces
peroxidation,
nitric
oxide,
activity,
which
may
be
influenced
by
regulation
TNF-α,
IL-6,
Bcl-2,
NF-kB,
BaX
via
Nrf2/HO-1
signaling
pathway
induced
DN.
Thus,
our
results
suggest
ameliorates
progression
STZ-induced
rats
NRF2/HO-1
mediated
pathways.
Further
comprehensive
studies
are
required
better
understand
underlying
Frontiers in Pharmacology,
Journal Year:
2020,
Volume and Issue:
11
Published: Dec. 11, 2020
Age-related
disorders
such
as
chronic
kidney
disease
(CKD)
are
increasingly
prevalent
globally
and
pose
unprecedented
challenges.
In
many
aspects,
CKD
can
be
viewed
a
state
of
accelerated
premature
aging.
Aging
share
common
characteristic
features
with
increased
cellular
senescence,
conserved
program
characterized
by
an
irreversible
cell
cycle
arrest
altered
transcriptome
secretome.
While
developmental
senescence
acute
may
positively
contribute
to
the
fine-tuning
embryogenesis
injury
repair,
when
unresolved
promptly,
plays
crucial
role
in
fibrogenesis
progression.
Senescent
cells
elicit
their
fibrogenic
actions
primarily
secreting
assortment
inflammatory
profibrotic
factors
known
senescence-associated
secretory
phenotype
(SASP).
Increasing
evidence
indicates
that
senescent
could
promising
new
target
for
therapeutic
intervention
senotherapy,
which
includes
depleting
cells,
modulating
SASP
restoration
inhibitors.
this
review,
we
discuss
current
understanding
mechanism
fibrosis.
We
also
highlight
potential
options
targeting
treatment
CKD.